Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas (Q30775012)

26 June 2017

title

Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas (English)

1 reference

26 June 2017

A Thiel

1 reference

26 June 2017

W D Heiss

1 reference

26 June 2017

K Herholz

1 reference

26 June 2017

A H Jacobs

1 reference

26 June 2017

A Winkler

1 reference

26 June 2017

C Dittmar

1 reference

26 June 2017

A Gossman

1 reference

26 June 2017

M Deckert

1 reference

26 June 2017

L Kracht

1 reference

26 June 2017

G Garlip

1 reference

26 June 2017

R Hilker

1 reference

26 June 2017

J Sobesky

1 reference

26 June 2017

S Vollmar

1 reference

26 June 2017

C Kummer

1 reference

26 June 2017

R Graf

1 reference

26 June 2017

J Voges

1 reference

26 June 2017

K Wienhard

1 reference

26 June 2017

publication date

1 June 2002

1 reference

Technology in Cancer Research and Treatment

26 June 2017

published in

1 reference

26 June 2017

1 reference

26 June 2017

1 reference

26 June 2017

page(s)

187-204

1 reference

Histopathology, classification, and grading of gliomas

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Glioma classification: a molecular reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Deletion mapping of chromosome 19 in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

MR-spectroscopy guided target delineation for high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

PET as a potential tool for imaging molecular mechanisms of oncology in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo imaging of glucose consumption and lactate concentration in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

FDG transport and phosphorylation in human gliomas measured with dynamic PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron emission tomography in patients with glioma. A predictor of prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Prediction of survival in glioma patients by means of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Glucose transport and apoptosis after gene therapy with HSV thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

11C-methionine PET for differential diagnosis of low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Cerebral glioma: evaluation with methionine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Amino acid uptake in ischemically compromised brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron emission tomography with injection of methionine as a prognostic factor in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Fluorinated amino acids for tumour imaging with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

[18F]FLT; portrait of a proliferation marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Functional MR and PET imaging of rolandic and visual cortices for neurosurgical planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Functional imaging in treatment planning of brain lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Activation PET scanning in pretreatment evaluation of patients with cerebral tumours or vascular lesions in or close to the sensorimotor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Preoperative Activation and Intraoperative Stimulation of Language-related Areas in Patients with Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Localization of language-related cortex with 15O-labeled water PET in patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Multimodal anatomic, functional, and metabolic brain imaging for tumor resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Interstitial radiosurgery of low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

CT-guided and computer assisted stereotactic biopsy. Technique, results, indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Functional activity within brain tumors: a magnetic source imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Researchers and regulators reflect on first gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo magnetic resonance imaging of transgene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

The development of in vivo imaging systems to study gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Green fluorescent protein as a marker for gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Bioluminescent indicators in living mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Resolution of multiple green fluorescent protein color variants and dyes using two-photon microscopy and imaging spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Noninvasive quantitative imaging of protein-protein interactions in living subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo imaging of oligonucleotides with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging transgene expression in live animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

[(11)C]FMAU and [(18)F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Quantification of target gene expression by imaging reporter gene expression in living animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Tricistronic and tetracistronic retroviral vectors for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Quantitation of HSV mass distribution in a rodent brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Optical imaging of Renilla luciferase reporter gene expression in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Optical imaging of cardiac reporter gene expression in living rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Bioluminescence imaging of lymphocyte trafficking in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo visualization of gene expression using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo assessment of adenoviral vector-mediated gene expression of dopamine D(2) receptors in the rat striatum by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Quantitative imaging of gene induction in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Detection and measurement of in vitro gene transfer by gamma camera imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

Measuring transferrin receptor gene expression by NMR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

In vivo molecular target assessment of matrix metalloproteinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460200100304

10.1177/153303460200100304

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference